Jul 14, 2026 · 13 min · 10 segments
Obstructive sleep apnea (OSA) is a condition that affects millions globally, causing daytime sleepiness, lack of oxygen, and higher risks of developing cardiac issues. A new randomized control trial…
Irene Cano-PumaregaGuest
Amy AttawayHost
So can you talk about kind of how the study was designed? And I know you're kind of focusing on positional obstructive sleep apnea and treating it, right? Is that correct?
And there are, like, between 50 and 2/3 of the patient have what we call positional sleep apnea.
That means that this, uh, apnea is more frequent when they are on their backs, okay? And for these type of patients, the gold standard treatment, that is the CPAP, is not very well-tolerated.
... that is a vibrating device, that it vibrates when the patient is on, uh, on the positional, in a supine position, on their back.
So we wanted to s- uh, assess on the, not only if it was an effective treatment-
So can you talk about kind of how the study was designed? And I know you're kind of focusing on positional obstructive sleep apnea and treating it, right? Is that correct?
And there are, like, between 50 and 2/3 of the patient have what we call positional sleep apnea.
That means that this, uh, apnea is more frequent when they are on their backs, okay? And for these type of patients, the gold standard treatment, that is the CPAP, is not very well-tolerated.
... that is a vibrating device, that it vibrates when the patient is on, uh, on the positional, in a supine position, on their back.
So we wanted to s- uh, assess on the, not only if it was an effective treatment-
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.
